IDH2 and angioimmunoblastic T-cell lymphoma: That said, AITL can involve the skin, and expression of TFH markers and detection of RHOA p.G17V and IDH2 p.R172K mutations in this context can suggest the differential diagnosis if staging information is not yet available [80].